Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Tumor necrosis factor (TNF) inhibitors have proven highly effective in improving the signs and symptoms of rheumatoid arthritis, in inhibiting the progression of joint damage, and improving patients' quality of life. This Viewpoint will discuss the major concern relating to the actual use of TNF inhibitors in the clinic: their relatively high acquisition costs.
Progress in our understanding of fibromyalgia has identified aberrant central pain processing as a key abnormality in affected individuals. This Review describes a multimodal approach to treating this central pain syndrome, using neuroactive drugs that modulate sensory processing, and nonpharmacologic therapies such as exercise and cognitive behavioral therapy.
The pathogenesis of the spondyloarthropathies is thought to relate to interactions between genes, including HLA-B27, bacteria, and innate and acquired immune responses. This Review provides an insight into the validity of the genes–bacteria–immune response paradigm, and explores how interactions between these factors might result in disease.
To achieve goodin vivofunction, engineered cartilage needs to exhibit biological and physical properties similar to those of native articular cartilage. Adult multipotent stem cells are considered the cell type of choice for cartilage tissue engineering; this emerging technology shows high promise for producing transplantable cartilage constructs to improve the function of degenerated joints.